4 matches for your search in the start-up spotlight
rss
Cambridge-based TRIMTECH Therapeutic’s mission is to create novel small molecule degraders of protein aggregates that will combat neurodegenerative and inflammatory diseases including Alzheimer’s disease, a leading cause of death globally. The Company’s proprietary degrader technology is focused ...
We reduce custom battery development cost and time by 10x for businesses who are electrifying, accelerating the transition to a clean economy. We believe everyone should have access to their perfect battery, without the barriers of expensive development and long lead times. We are developing ...
Electria Group - Experts delivering the people and the project resources for Electrification, Grid Development and Battery Technology. We enable climate shaping companies to develop a cleaner future through innovative product development and projects
Glox Therapeutics is developing a pipeline of engineered precision bacteriocins targeting pathogens that cause serious infections associated with high levels of antimicrobial resistance (AMR) and mortality. These novel precision antibiotics have potent narrow-spectrum activity to target ...
